Inflammation is a key component of the initiation and progression of diseases such as DMD, thus, activating the integrated signalling network involving Nrf2, NF-κB and HO-1 is a logical approach in DMD treatment. Here, NFE2L2 is linked to Duchenne muscular dystrophy.